Loading institutional data...
Loading institutional data...
Held by 564 of 5,944 reporting institutions (97th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $21.18 today, the market must believe free cash flow compounds -2.3%/yr for a decade (off $715M normalized FCF).
The market's -2.3% is more optimistic than its 9-yr track record.
2-stage DCF · 0.30B shares · net debt $630M
mean -3.9% · volatility σ 18% · implied rate exceeded in 4/9 yrs
Central path = implied -2.3%/yr growth; shaded band = ±1σ (18%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 65% of free cash flow, leaving room to grow it and fund buybacks. Last year: $459M dividends + $62M buybacks = $521M returned on $705M FCF.
1 consecutive years of dividend increases · 2%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 13%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $132M is below the $444M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2016-07-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~45.3% on $762M of debt.
Cash of $132M is below short-term debt of $762M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 64.1 | 66.8 | 65.5 | 66.8 | 69.3 | 68.8 | 69.2 | 69.6 |
| SG&A | 8.5 | 7.5 | 7.2 | 7.1 | 7.2 | 7.0 | 7.6 | 6.6 |
| Operating Income | 15.3 | 12.1 | 12.7 | 18.2 | 13.6 | 14.0 | 10.4 | 11.0 |
| Income Tax | 1.6 | 1.9 | 2.0 | 3.9 | 2.5 | 2.9 | 2.0 | 1.9 |
| Net Income | 3.9 | 2.6 | 18.7 | 11.8 | 8.8 | 9.2 | 5.9 | 5.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CPB: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.25B 100.0% | $9.64B 100.0% | $9.36B 100.0% | $8.56B 100.0% | $8.48B 100.0% | $8.69B 100.0% | $8.11B 100.0% | $6.62B 100.0% | $5.84B 100.0% | $7.96B 100.0% |
| Cost of Revenue | $7.13B 69.6% | $6.67B 69.2% | $6.44B 68.8% | $5.93B 69.3% | $5.67B 66.8% | $5.69B 65.5% | $5.41B 66.8% | $4.24B 64.1% | $3.40B 58.2% | $5.03B 63.2% |
| Cost of Products | — | — | — | — | — | — | — | $5.87B 88.7% | $4.96B 85.1% | $5.03B 63.2% |
| Selling, General & Admin | $674.0M 6.6% | $737.0M 7.6% | $654.0M 7.0% | $617.0M 7.2% | $598.0M 7.1% | $622.0M 7.2% | $610.0M 7.5% | $563.0M 8.5% | $448.0M 7.7% | $575.0M 7.2% |
| Total Operating Expenses | $9.13B 89.0% | $8.64B 89.6% | $8.04B 86.0% | $7.40B 86.4% | $6.93B 81.8% | $7.58B 87.3% | $7.13B 87.9% | $5.61B 84.7% | $4.41B 75.5% | $7.00B 87.9% |
| Operating Income | $1.12B 11.0% | $1.00B 10.4% | $1.31B 14.0% | $1.16B 13.6% | $1.54B 18.2% | $1.11B 12.7% | $979.0M 12.1% | $1.01B 15.3% | $1.43B 24.5% | $960.0M 12.1% |
| Interest Expense | $345.0M 3.4% | $249.0M 2.6% | $188.0M 2.0% | $189.0M 2.2% | $210.0M 2.5% | $345.0M 4.0% | $356.0M 4.4% | $183.0M 2.8% | $115.0M 2.0% | $115.0M 1.4% |
| Interest & Investment Income | $17.0M 0.2% | $6.0M 0.1% | $4.0M 0.0% | $1.0M 0.0% | $1.0M 0.0% | $4.0M 0.0% | $2.0M 0.0% | $3.0M 0.0% | $0 0.0% | $4.0M 0.1% |
| Other Income (Expense), net | -$273.0M -2.7% | -$261.0M -2.7% | -$32.0M -0.3% | -$21.0M -0.2% | $254.0M 3.0% | -$221.0M -2.5% | -$140.0M -1.7% | $73.0M 1.1% | $216.0M 3.7% | -$405.0M -5.1% |
| Pretax Income | $796.0M 7.8% | $757.0M 7.9% | $1.13B 12.1% | $975.0M 11.4% | $1.34B 15.8% | $766.0M 8.8% | $625.0M 7.7% | $830.0M 12.5% | $1.32B 22.5% | $849.0M 10.7% |
| Income Tax Expense | $194.0M 1.9% | $190.0M 2.0% | $270.0M 2.9% | $218.0M 2.5% | $328.0M 3.9% | $174.0M 2.0% | $151.0M 1.9% | $106.0M 1.6% | $392.0M 6.7% | $286.0M 3.6% |
| Net Income | $602.0M 5.9% | $567.0M 5.9% | $858.0M 9.2% | $757.0M 8.8% | $1.00B 11.8% | $1.63B 18.7% | $211.0M 2.6% | $261.0M 3.9% | $887.0M 15.2% | $563.0M 7.1% |
| Per Share | ||||||||||
| EPS (Basic) | $2.02 | $1.90 | $2.87 | $2.51 | $3.31 | $5.39 | $0.70 | $0.87 | $2.91 | $1.82 |
| EPS (Diluted) | $2.01 | $1.89 | $2.85 | $2.51 | $3.29 | $5.36 | $0.70 | $0.86 | $2.89 | $1.81 |
| Weighted Avg Shares (Basic) | 298.0M | 298.0M | 299.0M | 301.0M | 303.0M | 302.0M | 301.0M | 301.0M | 305.0M | 309.0M |
| Weighted Avg Shares (Diluted) | 300.0M | 300.0M | 301.0M | 302.0M | 305.0M | 304.0M | 302.0M | 302.0M | 307.0M | 311.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $858.2B | 39.4× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.1B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.1B | 28.9× | 24.8× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.5B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $298.3B | 26.4× | 17.4× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.9B | 22.4× | 15.0× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $117.4B | 17.0× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.7B | 33.0× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $70.0B | 19.0× | 10.2× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $69.7B | 33.1× | 19.4× | 3.4× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.6B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $43.2B | 20.8× | 14.5× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| FMX | $41.2B | — | — | — | — | — | — | — | — | — | 290 |
| ADM | $41.1B | 38.1× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| JBS | $40.2B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.9B | 39.7× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.4B | 21.1× | 9.6× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| HSY | $34.6B | — | 20.3× | 3.0× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $34.4B | — | 782.5× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KVUE | $34.2B | 23.5× | 11.6× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.1B | 18.0× | 8.0× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.2B | 31.6× | 18.9× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| CPB | $6.4B | 10.6× | 4.5× | 0.6× | 6.4% | 30.4% | 5.9% | 15.4% | 12.9% | 0.5× | 564 |
Peers = companies sharing CPB's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.